Junho Chung, M.D., Ph.D.

Professor at Seoul National University College of Medicine

Speaker

Dr. Junho Chung graduated from Seoul National University, College of Medicine and
received his M.D. degree. After his graduation, he joined a dual degree program at the same college
and obtained his Ph. D. degree as a molecular biology major under the supervision of Prof. Hong-
Keun Chung.
Then he joined the late Dr. Carlos F. Barbas III’s laboratory at The Scripps Research
Institute, La Jolla, CA, USA as a research associate, who is one of the pioneers in the field of
recombinant antibody engineering.
From 2000, Dr. Chung has been a faculty of Seoul National University, College of Medicine
at the Department of Biochemistry and Molecular Biology. He is also a founding member of
National Cancer Center Korea, in which he served as a director of basic science division for four
years as a dual duty.
His research has been focused on antibody engineering. He published more than 99 articles
in this field and invented more than 30 registered patents. Until now, sixteen of his patents and
know-hows were licensed to nine biotech companies. An anti-HGF antibody he invented
successfully finished Phase I clinical trial (ClinicalTrials.gov Identifier: NCT02499224, Safety and
Pharmacokinetics Study of YYB101 in Advanced Solid Tumors Patients Who Are Refractory to
Standard Therapy). And Phase II trial will begin shortly. Two other antibodies are in preclinical
development stage. Recently, he is also actively developing technologies applicable to the chimeric
antigen receptor T cell therapy too.